 |
PDBsum entry 1vgn
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Structure-based design of the irreversible inhibitors to metallo-- lactamase (imp-1)
|
|
Structure:
|
 |
Beta-lactamase imp-1. Chain: a, b. Synonym: metallo-beta-lactamase, beta-lactamase, type ii, penicillinase, blaimp. Engineered: yes
|
|
Source:
|
 |
Serratia marcescens. Organism_taxid: 615. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
2.63Å
|
R-factor:
|
0.228
|
R-free:
|
0.243
|
|
|
Authors:
|
 |
H.Kurosaki,Y.Yamaguchi,T.Higashi,K.Soga,S.Matsueda,S.Misumi, Y.Yamagata,Y.Arakawa,M.Goto
|
|
Key ref:
|
 |
H.Kurosaki
et al.
(2005).
Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester.
Angew Chem Int Ed Engl,
44,
3861-3864.
PubMed id:
|
 |
|
Date:
|
 |
|
27-Apr-04
|
Release date:
|
21-Jun-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P52699
(BLAB_SERMA) -
Metallo-beta-lactamase type 2 from Serratia marcescens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
246 a.a.
217 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Angew Chem Int Ed Engl
44:3861-3864
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester.
|
|
H.Kurosaki,
Y.Yamaguchi,
T.Higashi,
K.Soga,
S.Matsueda,
H.Yumoto,
S.Misumi,
Y.Yamagata,
Y.Arakawa,
M.Goto.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Oelschlaeger,
N.Ai,
K.T.Duprez,
W.J.Welsh,
and
J.H.Toney
(2010).
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
|
| |
J Med Chem,
53,
3013-3027.
|
 |
|
|
|
|
 |
F.R.Salsbury,
M.W.Crowder,
S.F.Kingsmore,
and
J.J.Huntley
(2009).
Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor.
|
| |
J Mol Model,
15,
133-145.
|
 |
|
|
|
|
 |
A.I.Anzellotti,
and
N.P.Farrell
(2008).
Zinc metalloproteins as medicinal targets.
|
| |
Chem Soc Rev,
37,
1629-1651.
|
 |
|
|
|
|
 |
A.Tamilselvi,
and
G.Mugesh
(2008).
Zinc and antibiotic resistance: metallo-beta-lactamases and their synthetic analogues.
|
| |
J Biol Inorg Chem,
13,
1039-1053.
|
 |
|
|
|
|
 |
N.Sharma,
Z.Hu,
M.W.Crowder,
and
B.Bennett
(2008).
Conformational changes in the metallo-beta-lactamase ImiS during the catalytic reaction: an EPR spectrokinetic study of Co(II)-spin label interactions.
|
| |
J Am Chem Soc,
130,
8215-8222.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |